Cargando…
Olfactory dysfunction in patients with primary progressive MS
OBJECTIVE: We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS). METHODS: Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs)...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471346/ https://www.ncbi.nlm.nih.gov/pubmed/28638852 http://dx.doi.org/10.1212/NXI.0000000000000369 |
_version_ | 1783243933168435200 |
---|---|
author | Schmidt, Felix A. Maas, Matthew B. Geran, Rohat Schmidt, Charlotte Kunte, Hagen Ruprecht, Klemens Paul, Friedemann Göktas, Önder Harms, Lutz |
author_facet | Schmidt, Felix A. Maas, Matthew B. Geran, Rohat Schmidt, Charlotte Kunte, Hagen Ruprecht, Klemens Paul, Friedemann Göktas, Önder Harms, Lutz |
author_sort | Schmidt, Felix A. |
collection | PubMed |
description | OBJECTIVE: We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS). METHODS: Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs). Patients with olfactory dysfunction due to an alternative primary etiology were excluded. The validated olfactory testing method yielded individual scores for olfactory threshold, odor discrimination, and odor identification, along with a composite Threshold Discrimination Identification (TDI) score. RESULTS: Olfactory dysfunction was identified in 27 (84%) patients with PPMS, 10 (31%) patients with RRMS, and 1 (3%) HC. While age and sex were similar between PPMS and HCs, the TDI score and all olfactory subscores were significantly worse in patients with PPMS compared with HCs (all p < 0.001). After adjustment for differences in age, sex, Expanded Disability Status Scale (EDSS), and disease duration, odor discrimination, odor identification, and the composite TDI score were worse in patients with PPMS vs RRMS (p = 0.03, 0.04, and 0.02, respectively). Neither age, sex, EDSS, nor disease duration was significantly associated with the composite TDI score. CONCLUSIONS: Olfactory dysfunction was more frequent and severe in PPMS compared with RRMS, independent of disease duration and overall disability status. Further research on cellular level differences in olfactory neural pathways may lead to new insights about disease pathogenesis in MS. |
format | Online Article Text |
id | pubmed-5471346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-54713462017-06-21 Olfactory dysfunction in patients with primary progressive MS Schmidt, Felix A. Maas, Matthew B. Geran, Rohat Schmidt, Charlotte Kunte, Hagen Ruprecht, Klemens Paul, Friedemann Göktas, Önder Harms, Lutz Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS). METHODS: Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs). Patients with olfactory dysfunction due to an alternative primary etiology were excluded. The validated olfactory testing method yielded individual scores for olfactory threshold, odor discrimination, and odor identification, along with a composite Threshold Discrimination Identification (TDI) score. RESULTS: Olfactory dysfunction was identified in 27 (84%) patients with PPMS, 10 (31%) patients with RRMS, and 1 (3%) HC. While age and sex were similar between PPMS and HCs, the TDI score and all olfactory subscores were significantly worse in patients with PPMS compared with HCs (all p < 0.001). After adjustment for differences in age, sex, Expanded Disability Status Scale (EDSS), and disease duration, odor discrimination, odor identification, and the composite TDI score were worse in patients with PPMS vs RRMS (p = 0.03, 0.04, and 0.02, respectively). Neither age, sex, EDSS, nor disease duration was significantly associated with the composite TDI score. CONCLUSIONS: Olfactory dysfunction was more frequent and severe in PPMS compared with RRMS, independent of disease duration and overall disability status. Further research on cellular level differences in olfactory neural pathways may lead to new insights about disease pathogenesis in MS. Lippincott Williams & Wilkins 2017-06-14 /pmc/articles/PMC5471346/ /pubmed/28638852 http://dx.doi.org/10.1212/NXI.0000000000000369 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Schmidt, Felix A. Maas, Matthew B. Geran, Rohat Schmidt, Charlotte Kunte, Hagen Ruprecht, Klemens Paul, Friedemann Göktas, Önder Harms, Lutz Olfactory dysfunction in patients with primary progressive MS |
title | Olfactory dysfunction in patients with primary progressive MS |
title_full | Olfactory dysfunction in patients with primary progressive MS |
title_fullStr | Olfactory dysfunction in patients with primary progressive MS |
title_full_unstemmed | Olfactory dysfunction in patients with primary progressive MS |
title_short | Olfactory dysfunction in patients with primary progressive MS |
title_sort | olfactory dysfunction in patients with primary progressive ms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471346/ https://www.ncbi.nlm.nih.gov/pubmed/28638852 http://dx.doi.org/10.1212/NXI.0000000000000369 |
work_keys_str_mv | AT schmidtfelixa olfactorydysfunctioninpatientswithprimaryprogressivems AT maasmatthewb olfactorydysfunctioninpatientswithprimaryprogressivems AT geranrohat olfactorydysfunctioninpatientswithprimaryprogressivems AT schmidtcharlotte olfactorydysfunctioninpatientswithprimaryprogressivems AT kuntehagen olfactorydysfunctioninpatientswithprimaryprogressivems AT ruprechtklemens olfactorydysfunctioninpatientswithprimaryprogressivems AT paulfriedemann olfactorydysfunctioninpatientswithprimaryprogressivems AT goktasonder olfactorydysfunctioninpatientswithprimaryprogressivems AT harmslutz olfactorydysfunctioninpatientswithprimaryprogressivems |